PRCT PROCEPT BioRobotics Corporation
Healthcare$27.45-5.34%ClosedMarket Cap: $1.56B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.71
P/S
5.13
EV/EBITDA
-14.23
DCF Value
$47.67
FCF Yield
-4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
63.0%
Operating Margin
-33.9%
Net Margin
-31.8%
ROE
-27.7%
ROA
-21.0%
ROIC
-25.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $83.1M | 64.9% | $-32.6M | $-31.6M | $— | — |
| Q4 null | $76.4M | 60.6% | $-31.0M | $-29.8M | $— | — |
| FY null | $308.1M | 63.7% | $-103.9M | $-95.6M | $— | — |
| Q3 null | $83.3M | 62.9% | $-23.2M | $-21.4M | $— | — |
| Q2 null | $79.2M | 63.3% | $-22.2M | $-19.6M | $— | — |
| Q1 null | $69.2M | 63.9% | $-27.4M | $-24.7M | $— | — |
| Q4 null | $68.2M | 64.0% | $-19.7M | $-18.9M | $— | — |
| FY null | $224.5M | 61.1% | $-96.6M | $-91.4M | $— | — |
| Q3 null | $58.4M | 63.2% | $-22.4M | $-21.0M | $— | — |
| Q2 null | $53.4M | 59.0% | $-26.8M | $-25.6M | $— | — |
| Q1 null | $44.5M | 56.2% | $-27.6M | $-26.0M | $— | — |
| Q4 2023 | $43.6M | 48.8% | $-29.6M | $-27.5M | $-0.54 | — |